Back
NovoCure Stock Price Chart
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77
NVCR
NovoCure
Last Price:
28.81
Seasonality Move:
2.04%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.
NovoCure Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.45 | Buy |
| 20-day SMA: | 18.85 | Buy |
| 50-day SMA: | 17.12 | Buy |
| 200-day SMA: | 17.34 | Buy |
| 8-day EMA: | 23.1 | Buy |
| 20-day EMA: | 19.92 | Buy |
| 50-day EMA: | 18.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
NovoCure Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 84.56 | Buy |
| Chaikin Money Flow: | -690353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 22.01) | Buy |
| Bollinger Bands (100): | (15.44 - 20.28) | Buy |
NovoCure Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovoCure Stock
Is NovoCure Stock a Buy?
- NovoCure share price is 30.51 while NVCR 8-day simple moving average is 21.45, which is a Buy signal.
- The stock price of NVCR is 30.51 while NovoCure 20-day SMA is 18.85, which makes it a Buy.
- NovoCure 50-day simple moving average is 17.12 while NVCR share price is 30.51, making it a Buy technically.
- NVCR stock price is 30.51 and NovoCure 200-day simple moving average is 17.34, creating a Buy signal.
NVCR Technical Analysis vs Fundamental Analysis
NovoCure Stock Info
Market Cap:
3.3B
Price in USD:
30.51
Share Volume:
3.89M
NovoCure 52-Week Range
52-Week High:
32.60
52-Week Low:
11.66
Buy
77
NovoCure (NVCR)
is a Buy
NovoCure Share Price Forecast
-
What is the NovoCure stock price today?
The NovoCure stock price is 30.51 USD today. -
Will NVCR stock go up or go down?
NovoCure> share price is forecast to RISE/FALL based on technical indicators -
Is NovoCure overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is not overvalued.
Is NovoCure Stock a Buy?
- NovoCure share price is 30.51 while NVCR 8-day exponential moving average is 23.10, which is a Buy signal.
- The stock price of NVCR is 30.51 while NovoCure 20-day EMA is 19.92, which makes it a Buy.
- NovoCure 50-day exponential moving average is 18.23 while NVCR share price is 30.51, making it a Buy technically.
- NVCR stock price is 30.51 and NovoCure 200-day simple moving average is 19.07, creating a Buy signal.
Fundamental Analysis of NovoCure
Is NovoCure a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Technical Analysis of NovoCure
Should I short NovoCure stock?
- NVCR Moving Average Covergence Divergence (MACD) indicator is 2.24, suggesting NovoCure is a Buy
- NovoCure Relative Strength Index (RSI) is 84.56, which suggest NovoCure is overbought
- The Bollinger Bands (25) for NovoCure is (14.69 - 22.01), which suggest NovoCure is a Buy
- The Bollinger Bands (100) for NovoCure is (15.44 - 20.28), which suggest NovoCure is a Buy
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.